Solta Buys LipoSonix Noninvasive Fat Ablation Tech To Expand Aesthetics Biz
This article was originally published in The Gray Sheet
Aesthetics device firm Solta Medical is moving beyond skin aesthetics to the noninvasive fat-removal space with its acquisition of Medicis Pharmaceutical’s LipoSonix technology business unit.
You may also be interested in...
NuPathe and its migraine patch product Zecuity are the latest acquisition by Endo since former Valeant executive Rajiv De Silva moved into the chief executive’s office – will he succeed in bringing his former company’s model to the specialty firm? Plus, Valeant made its own news during the week, while AstraZeneca bought out Bristol’s share of their diabetes joint venture, and more.
Valeant Pharmaceuticals says it will buy energy-based aesthetics device firm Solta Medical for about $250 million, to expand the breadth of its offerings to dermatologists and plastic surgeons.
St. Jude Medical’s Ilumien